Literature DB >> 19494595

Biological markers in the peritoneal dialysate effluent: are they useful.

Raymond T Krediet, Denise E Sampimon, Anniek Vlijm, Annemieke M Coester, Dirk G Struijk, Watske Smit.   

Abstract

A review is given on biomarkers in peritoneal effluent. It comprises methods to distinguish between diffusion and local production. This is followed by examples of various biomarkers. Their potential use is discussed in 4 situations: inherent fast transporters, longitudinal follow-up of patients, biocompatibility testing of new dialysis solutions, and their potential use in the detection of patients who are likely to develop encapsulating peritoneal sclerosis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19494595     DOI： 10.1159/000223780

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


  8 in total

Review 1.  Encapsulating peritoneal sclerosis: a single-center experience and review of the literature.

Authors:  Konstantina Trigka; Periklis Dousdampanis; Maggie Chu; Saimah Khan; Mufazzal Ahmad; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2010-10-06       Impact factor: 2.370

2.  Dialysate CA125 levels after 5 years on continuous peritoneal dialysis.

Authors:  Cengiz Candan; Pınar Turhan; Lale Sever; Mahmut Civilibal; Nur Canpolat; Salim Caliskan; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2011-01-29       Impact factor: 3.714

3.  Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?

Authors:  Deirisa Lopes Barreto; Annemieke M Coester; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2013-09-01       Impact factor: 1.756

Review 4.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

Review 5.  Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.

Authors:  Panida Ditsawanon; Ouppatham Supasyndh; Pornanong Aramwit
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

Review 6.  Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data.

Authors:  Tom Cornelis; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2010-05-07       Impact factor: 2.370

7.  Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells.

Authors:  Ikuko Oba-Yabana; Takefumi Mori; Chika Takahashi; Takuo Hirose; Yusuke Ohsaki; Satoshi Kinugasa; Yoshikazu Muroya; Emiko Sato; Geneviève Nguyen; Rémi Piedagnel; Pierre M Ronco; Kazuhito Totsune; Sadayoshi Ito
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

8.  Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures.

Authors:  Rebecca Herzog; Michael Boehm; Markus Unterwurzacher; Anja Wagner; Katja Parapatics; Peter Májek; André C Mueller; Anton Lichtenauer; Keiryn L Bennett; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Mol Cell Proteomics       Date:  2017-12-04       Impact factor: 5.911
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.